Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06234592
NA

The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock

Sponsor: King's College Hospital NHS Trust

View on ClinicalTrials.gov

Summary

Acute kidney injury (AKI) is a common complication of septic shock and together these conditions carry a high mortality risk. In septic patients who develop severe AKI renal cortical perfusion is deficient despite normal macrovascular organ blood flow. This intra-renal perfusion abnormality may be amenable to pharmacological manipulation, which may offer mechanistic insight into the pathophysiology of septic AKI. The aim of the current study is to investigate the effects of vasopressin and angiotensin II on renal microcirculatory perfusion in a cohort of patients with septic shock.

Official title: The Effect of Vasopressor Therapy on Renal Perfusion in Patients With Septic Shock - a Mechanistically Focussed Randomized Control Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-01-05

Completion Date

2026-07

Last Updated

2025-04-04

Healthy Volunteers

No

Interventions

DRUG

Angiotensin II

Angiotensin II infusion

DRUG

Vasopressin

Vasopressin infusion

DRUG

Norepinephrine

Standard care vasopressor therapy, norepinephrine infusion

Locations (1)

King's College Hospital

London, United Kingdom